<p>Human MM cell lines were treated with different concentrations (0–100 μM) of cisplatin or Dox (0–25 μM) for 24 or 48 h and steady-state PYCARD/ASC or pro-caspase-1 mRNA levels were assessed by qRT-PCR. *p≤0.05 as compared to untreated (0) controls at the same time point.</p
The aim of our study was to determine the effect of selected cytostatics on a human ovarian cancer c...
<p>Cells were exposed 24 h to oxaliplatin (OXA) (2–200 µM). P2X7 receptor activation (A) was evaluat...
<p>(A) Western blot analysis indicated increased levels of p53 and phospho-p53 after 6 and 24 h of c...
<p>Human MM cell lines were treated with different concentrations (0–100 μM) of cisplatin or Dox (0–...
<p>MTS assay performed to measure cell viability on Hmeso or H2373 MM cells in presence of Dox or ci...
<p>Treatment of Hmeso MM cells with Dox or cisplatin resulted in increased NLRP3 protein levels (A) ...
<p>(A) Hmeso MM cells treated with either Dox or cisplatin caused increased release of HMGB1, FGF2, ...
Previous studies have demonstrated that mitomycin C (MMC) and other DNA cross-linking agents can sup...
<p>shRNA-CLPTM1L transfected 95-D cells and control cells were treated with 50 uM cisplatin for 24 h...
This study measures the time-dependence of cellular caspase activation by anticancer drugs and compa...
<p>, H292 cells were transfected with scramble shRNA or shRNA against HDAC6 to generate H292-pRS or ...
Patients with head and neck squamous cell carcinoma (HNSCC) treated with cisplatin show a large inte...
The shape of the dose-response curve (DRC) has been hypothesized to reflect mechanisms of resistance...
<p>P2X7 receptor (P2X7R) activation was evaluated using YOPRO-1 test and chromatin condensation usin...
<p>Cells were treated with vehicle (Untreated Control), indicated doses of Cisplatin, various CFMs, ...
The aim of our study was to determine the effect of selected cytostatics on a human ovarian cancer c...
<p>Cells were exposed 24 h to oxaliplatin (OXA) (2–200 µM). P2X7 receptor activation (A) was evaluat...
<p>(A) Western blot analysis indicated increased levels of p53 and phospho-p53 after 6 and 24 h of c...
<p>Human MM cell lines were treated with different concentrations (0–100 μM) of cisplatin or Dox (0–...
<p>MTS assay performed to measure cell viability on Hmeso or H2373 MM cells in presence of Dox or ci...
<p>Treatment of Hmeso MM cells with Dox or cisplatin resulted in increased NLRP3 protein levels (A) ...
<p>(A) Hmeso MM cells treated with either Dox or cisplatin caused increased release of HMGB1, FGF2, ...
Previous studies have demonstrated that mitomycin C (MMC) and other DNA cross-linking agents can sup...
<p>shRNA-CLPTM1L transfected 95-D cells and control cells were treated with 50 uM cisplatin for 24 h...
This study measures the time-dependence of cellular caspase activation by anticancer drugs and compa...
<p>, H292 cells were transfected with scramble shRNA or shRNA against HDAC6 to generate H292-pRS or ...
Patients with head and neck squamous cell carcinoma (HNSCC) treated with cisplatin show a large inte...
The shape of the dose-response curve (DRC) has been hypothesized to reflect mechanisms of resistance...
<p>P2X7 receptor (P2X7R) activation was evaluated using YOPRO-1 test and chromatin condensation usin...
<p>Cells were treated with vehicle (Untreated Control), indicated doses of Cisplatin, various CFMs, ...
The aim of our study was to determine the effect of selected cytostatics on a human ovarian cancer c...
<p>Cells were exposed 24 h to oxaliplatin (OXA) (2–200 µM). P2X7 receptor activation (A) was evaluat...
<p>(A) Western blot analysis indicated increased levels of p53 and phospho-p53 after 6 and 24 h of c...